legal

Health By Andrew Joseph

A new book traces the roots of the opioid crisis through the secretive Sackler family

Pharmalot By Ed Silverman

A drug maker sues a medical journal, its editor, and several authors for libel

Pharmalot By Ed Silverman

A U.S. appeals court upholds the FTC view of controversial pay-to-delay settlements

Pharmalot By Ed Silverman

Brazilian judge temporarily suspends pharmaceutical patent extensions amid push to lower drug costs

Pharmalot By Ed Silverman

Universities launch opioid litigation archive to ‘ensure history doesn’t repeat itself’

Pharmalot By Ed Silverman

AbbVie accuses a company of recruiting an employee in order to steal Humira secrets

Pharmalot By Ed Silverman

‘The public is being denied the truth’: A legal expert blasts Purdue’s bankruptcy plan to end opioid lawsuits

Biotech By Erin Brodwin

SEC charges co-founders of shuttered microbiome startup uBiome with $60 million fraud

Pharmalot By Ed Silverman

Pharma wins a round in a battle with HHS over a drug discount program for hospitals

Pharmalot By Ed Silverman

Insulin makers win a significant round in Minnesota lawsuit accusing them of racketeering

Pharmalot By Ed Silverman

Pharmalittle: U.S. sits on millions of AstraZeneca vaccine doses; WTO again fails to act on Covid-19 proposal

First Opinion By Matthew Lane

Choosing the right director for the U.S. Patent and Trademark Office can help lower drug prices

First Opinion By Jacob S. Sherkow

Reining in drug patents isn’t a silver bullet against high drug prices

Pharmalot By Ed Silverman

Ohio attorney general sues a health plan over its PBM contracts and Medicaid costs

First Opinion By Steve Cohen

Instead of prior authorization, insurers should go back to the old ‘pay-and-chase’ model

Pharmalot By Ed Silverman

New Mexico attorney general accuses Gilead of blocking competition to its HIV medicines

Pharmalot By Ed Silverman

A U.S. court ruling may force biologics makers to review patent protections

First Opinion By Aaron Siri

Federal law prohibits employers and others from requiring vaccination with a Covid-19 vaccine distributed under an EUA

Pharmalot By Ed Silverman

Bristol Myers and Sanofi ordered to pay $834 million to Hawaii for withholding Plavix label

Pharmalot By Ed Silverman

Drug maker agrees to plead guilty to hiding and destroying records before FDA inspection

Pharmalot By Ed Silverman

To the delight of generic drug makers, federal appeals court tosses controversial ‘skinny labeling’ decision

Pharmalot By Ed Silverman

McKinsey agrees to $573 million settlement over advice given Purdue and other opioid makers

Politics By Rachel Cohrs

Biden administration pumps brakes on signature Trump drug pricing proposal

Pharmalot By Ed Silverman

‘Use that money wisely’: Coalition urges governments to spend opioid settlement funds on evidence-based efforts

Pharmalot By Ed Silverman

FTC sues drug makers over allegedly illegal deal over an opioid painkiller